Stay updated on Elranatamab in Refractory Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Elranatamab in Refractory Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Elranatamab in Refractory Multiple Myeloma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-17T13:46:30.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-10T14:47:47.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    The study record history shows an update from Revision: v3.6.6 to Revision: v3.7.0, indicating a system/version update to the page display without changing the underlying study information.
    Difference
    0.1%
    Check dated 2026-09-19T21:59:17.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    The page's Revision label changed from v3.6.5 to v3.6.6 on the Record History page.
    Difference
    0.1%
    Check dated 2026-08-29T21:56:33.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    The page history now shows Revision: v3.6.5, replacing v3.6.4. This indicates a small platform update to the Study Record History page without altering its data or user-facing functionality.
    Difference
    0.1%
    Check dated 2026-08-08T17:07:29.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    A new revision entry v3.6.4 has been added to the study record history, and the previous v3.6.3 entry has been removed.
    Difference
    0.1%
    Check dated 2026-07-25T09:55:21.000Z thumbnail image

Stay in the know with updates to Elranatamab in Refractory Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Elranatamab in Refractory Multiple Myeloma Clinical Trial page.